Developer docs
API playgroundTry for free, no card

Search company profiles

Enosium Life Science

Full company profile

uuid000jvda

Namestring
Enosium Life Science
Legal namestring
Advisantis Consulting SARL
Websiteurl
enosium.com
Company typeenum
Private
Founded yearint
2024
Descriptiontext

Enosium Life Science is a Paris-headquartered European scientific services group founded in January 2024 by Dr. Antoine Amer with financial backing from Otium Capital, a French private investment firm with approximately €1.5 billion in assets under management specializing in Buy & Build strategies. The group serves pharmaceutical, biotechnology, and medical technology companies across Europe, providing consulting services spanning the healthcare product value chain. Following three strategic acquisitions completed in October 2024 (Inbeeo for market access and pricing strategy, Vyoo Agency for health economics and HEOR, and the Epione group comprising KPL Paris, Alinéa Plus, and Sirius Customizer for medical affairs and scientific communication) and the April 2025 acquisition of Rweality for real-world evidence and health technology assessment, Enosium operates through six retained-brand subsidiaries alongside five integrated service pillars: Clinical Research (CRO), Regulatory Affairs, Market Access & Health Economics, Medical Affairs, and Marketing & Commercial Strategies.

The business model is professional services revenue. Each subsidiary maintains its own client relationships and brand identity while benefiting from group synergies, shared commercial resources, and coordinated business development by senior leaders including the CEO and Head of Medico-Marketing and Business Development. Pricing is custom and project-based, with multi-year contract cadences typical of enterprise healthcare engagements; no public pricing tiers or per-unit economics are disclosed. The group targets enterprise pharmaceutical, biotech, and medtech clients, and revenue is generated through project-based engagements and retainer contracts. The underlying technology stack is intentionally lean — value derives primarily from human expertise, with no proprietary platform or technology product at the core. The May 2025 partnership with UK-based Page & Page Health provides access to PIRL, an AI-powered insights tool that supports strategic decision-making and communication across engagements.

Following the October 2024 acquisitions, consolidated revenue reached approximately €15 million with a team of approximately 70 employees; the April 2025 integration of Rweality expanded headcount further. The group's stated strategic ambition is to reach several hundred million euros in revenue within five years through continued external growth. Enosium does not use resellers or intermediaries and operates through direct enterprise sales across the European market.

Short descriptiontext

Enosium Life Science is a Paris-based European scientific services group that provides consulting in clinical research, regulatory affairs, market access, medical affairs, and marketing to pharmaceutical, biotech, and medtech companies, built through a Buy & Build acquisition strategy.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersParis, France
HQ citystring
Paris
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical research services, market access consulting, health economics research, regulatory affairs consulting, medical affairs services
Industry4 codes
PRIMARYHLAGAKAI
Clinical Quality Assurance (GCP QA, TMF/QMS oversight)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAKAL
Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAKAO
Third-Party/Outsourced Quality & Responsible Person Services (EU QP/RP, US Agent)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYMPAAADAD
Healthcare & Life Sciences PR
Media, Entertainment & Sports/Advertising, Marketing & PR Services/Public Relations & Communications Agencies
NAICS code3 codes
  • Other Scientific and Technical Consulting Services54169
  • Other Scientific and Technical Consulting Services541690
  • Professional, Scientific, and Technical Services541
SIC code3 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Engineering, Accounting, Research, Management8700
  • Services-Misc Health & Allied Services, Nec8090
Product category
Pharmaceutical Consulting Services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Scientific Consulting Services
TypeProfessional Services
Description

Enosium Life Science generates revenue through providing specialized scientific consulting services to pharmaceutical, biotech and medtech companies across five core areas: clinical research (CRO), regulatory affairs, market access and health economics, medical affairs, and marketing. Services include strategic advisory, clinical studies, medical writing, biostatistics, market access strategy, pricing strategy, scientific communication, and marketing campaign development. Revenue is generated through project-based engagements and retainer contracts with healthcare industry clients.

enosium.com
2Subsidiary Service Revenue
TypeProfessional Services
Description

Each subsidiary (Inbeeo, Vyoo Agency, KPL Paris, Sirius Customizer, Alinéa Plus, Rweality) provides specialized services that contribute to the group's consolidated revenue. Each operates with its own client relationships while benefiting from group synergies and commercial resources.

enosium.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Pricing details1 tier
1Custom project-based engagements for pharmaceutical and biotech clients
ModelOtherBilling cadenceMulti-year contract
Notes

Enosium Life Science operates as a professional services firm with custom engagement pricing based on project scope, duration, and specialization requirements. No public pricing tiers are available.

enosium.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Enosium Life Science is a European scientific services group that delivers specialized consulting across the healthcare product value chain for pharmaceutical, biotech, and medtech companies. Its offering spans five integrated pillars — clinical research (CRO), regulatory affairs, market access & health economics, medical affairs, and marketing — delivered through six wholly-owned subsidiaries (Inbeeo, Vyoo Agency, KPL Paris, Sirius Customizer, Alinéa Plus, Rweality) operating across France, the UK, and broader Europe.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Enosium Life Science is a European integrated scientific services group offering a portfolio of complementary subsidiaries and five core service pillars covering the entire healthcare product value chain. The group comprises six acquired specialized companies: Inbeeo (market access/pricing strategy), Vyoo Agency (health economics/HEOR), KPL Paris (medical affairs), Sirius Customizer (strategic consulting/patient journey), Alinéa Plus (scientific events/publishing), and Rweality (real-world evidence/HTA). These subsidiaries operate alongside five integrated service pillars: Clinical Research (CRO), Regulatory Affairs, Market Access & Health Economics, Medical Affairs, and Marketing & Commercial Strategies. The model combines local expertise with international reach, serving pharmaceutical, biotech, and MedTech industries across Europe.

Product and service11 records
1Inbeeo
CategoryMarket Access Consulting
Description

Market access and pricing strategy consulting for pharmaceutical and MedTech companies in Europe, using a data-driven approach to define, communicate, and optimize innovation value from clinical development through lifecycle management.

2Vyoo Agency
CategoryHealth Economics Consulting
Description

Health economics and outcomes research (HEOR) consultancy providing cost-effectiveness and budget impact analyses using advanced modeling tools to compare and prioritize medical strategies based on clinical benefit and economic efficiency.

3KPL Paris
CategoryMedical Affairs Consulting
Description

Medical affairs consultancy in France dedicated to developing and executing tailored medical and medico-marketing strategies, including data analysis, medical education, KOL management, digital transformation, and patient experience optimization.

4Sirius Customizer
CategoryStrategic Healthcare Consulting
Description

Strategic consulting firm for the health, pharma, and MedTech sectors, providing care pathway optimization, market access strategies, public affairs, and communication through a network of experts.

5Alinéa Plus
CategoryScientific Events and Publishing
Description

Scientific events and medical publishing specialist with over 20 years of experience, offering tailored solutions for in-person, digital, and hybrid events and collaborating with scientific societies.

6Rweality
CategoryReal-World Evidence Consulting
Description

Real-world evidence (RWE) and health technology assessment consultancy providing end-to-end solutions including RWE generation, market access and pricing strategy, HEOR, organizational impact on healthcare systems, and field market access operations.

7Clinical Research (CRO)
CategoryClinical Research
Description

Clinical research services spanning Phase III through real-world studies and early access programs, including clinical studies, medical writing, biostatistics, real-world data, and early access expertise for pharmaceutical and biotech clients.

8Regulatory Affairs
CategoryRegulatory Affairs
Description

Regulatory strategy, submission, pharmacovigilance, quality assurance, and regulatory compliance services for healthcare products across European markets.

9Market Access & Health Economics
CategoryMarket Access and HEOR
Description

Access strategy, HEOR, pricing and reimbursement, value-based healthcare, and public affairs services designed to optimize market access and demonstrate product value to payers and health systems.

10Medical Affairs
CategoryMedical Affairs
Description

Medical strategy, scientific communication, data generation, and medical education/training services to support medical stakeholders and drive evidence-based healthcare decisions.

11Marketing & Commercial Strategies
CategoryHealthcare Marketing
Description

Brand strategy, communication campaigns, multi-channel marketing, market research, and go-to-market and commercial excellence services for pharmaceutical and healthcare products.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-05-12
Description

Strategic partnership announced May 12, 2025 between Enosium Life Science and UK-based Page & Page Health. The alliance combines scientific, strategic, creative, and commercial expertise to provide end-to-end solutions for pharmaceutical, biotech, and medtech companies throughout the product lifecycle. Key element is access to PIRL, Page & Page Health's AI-powered insights tool. The partnership enables earlier value articulation in product lifecycles and provides clients with integrated support from clinical development through commercialization.

Strategic tierCoreTypeOthersAnnounced on2025-04-01
Description

Rweality was acquired by Enosium Life Science in April 2025. It is a consulting firm specializing in real-world evidence and health technology assessment. Rweality brings expertise in market access, pricing strategy, health economics (HEOR), organizational impact on healthcare systems, and field market access operations. The acquisition strengthens Enosium's capabilities in healthcare data valuation and market access services.

Strategic tierCoreTypeOthersAnnounced on2024-10-03
Description

Inbeeo is a leading consulting firm specializing in market access and pricing strategies for pharmaceutical drugs and medical devices in Europe. Specializes in data-driven approaches to help define, communicate, and optimize the value of innovations from clinical development to lifecycle management.

Strategic tierCoreTypeOthersAnnounced on2024-10-03
Description

Vyoo Agency is one of the few companies highly specialized in health economics and outcomes research (HEOR). Provides cost-effectiveness and budget impact analyses using advanced modeling tools to compare and prioritize medical strategies based on clinical benefit and economic efficiency.

Strategic tierCoreTypeOthersAnnounced on2024-10-03
Description

Epione Group comprises three entities: KPL (French specialist in medical affairs and medico-marketing strategies), Alinéa Plus (expert in scientific events and medical publishing with over 20 years of experience), and Sirius Customizer (strategic consulting for care pathway optimization and market access). The group brings expertise in medical communication, scientific events, and patient journey optimization.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Swiss-based testing, inspection, and certification giant with a life sciences division offering CRO and consulting services. Similar Buy & Build DNA applied across life sciences services, with greater scale and global footprint.

2ZS Associates
TypeDirect peer
Description

Global consulting firm specializing in pharmaceutical sales, marketing, and market access strategy. Directly competes with Enosium's Market Access and Commercial Strategies pillars for pharma client engagements.

TypeBroad incumbent
Description

Global leader in clinical research, real-world evidence, and life sciences consulting. IQVIA competes with Enosium's CRO and market access pillars at the enterprise scale Enosium aspires to reach, and serves the same pharma/biotech client base.

TypeBroad incumbent
Description

Biopharma solutions organization combining CRO services with commercial and medical affairs capabilities. Closely mirrors Enosium's combined CRO + Medical Affairs + Marketing pillars, serving the same pharmaceutical clients.

TypeBroad incumbent
Description

Global CRO and biopharmaceutical services provider offering clinical research, regulatory, and market access services. Competes with Enosium across multiple pillars and serves the same European pharma client base.

TypeBroad incumbent
Description

European-headquartered life sciences services conglomerate built through aggressive M&A. Comparable to Enosium's PE-backed Buy & Build strategy applied to life sciences services, though at much larger scale.

TypeBroad incumbent
Description

Major global CRO offering clinical research, laboratory, and consulting services. Directly comparable to Enosium's Clinical Research pillar and competes for the same enterprise pharma clients across Europe.

TypeBroad incumbent
Description

Major life sciences services platform offering CRO, research models, and consulting services. A benchmark for what a mature, scaled life sciences services roll-up can become — relevant peer for Enosium's growth trajectory.

TypeDirect peer
Description

European-headquartered regulatory affairs and pharmacovigilance consulting firm, also built through PE-backed roll-up strategy. Most directly comparable peer to Enosium, competing in regulatory affairs, market access, and quality compliance.

TypeOthers
Description

UK-based healthcare communications agency and Enosium's strategic partner. Provides communications, creative, and PIRL AI insights capabilities to Enosium clients; adjacent service provider rather than competitor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries7 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Enosium Life Science

Pharmaceutical Consulting Servicesenosium.com

Enosium Life Science is a Paris-based European scientific services group that provides consulting in clinical research, regulatory affairs, market access, medical affairs, and marketing to pharmaceutical, biotech, and medtech companies, built through a Buy & Build acquisition strategy.

What Enosium Life Science does

Enosium Life Science is a Paris-headquartered European scientific services group founded in January 2024 by Dr. Antoine Amer with financial backing from Otium Capital, a French private investment firm with approximately €1.5 billion in assets under management specializing in Buy & Build strategies. The group serves pharmaceutical, biotechnology, and medical technology companies across Europe, providing consulting services spanning the healthcare product value chain. Following three strategic acquisitions completed in October 2024 (Inbeeo for market access and pricing strategy, Vyoo Agency for health economics and HEOR, and the Epione group comprising KPL Paris, Alinéa Plus, and Sirius Customizer for medical affairs and scientific communication) and the April 2025 acquisition of Rweality for real-world evidence and health technology assessment, Enosium operates through six retained-brand subsidiaries alongside five integrated service pillars: Clinical Research (CRO), Regulatory Affairs, Market Access & Health Economics, Medical Affairs, and Marketing & Commercial Strategies.

The business model is professional services revenue. Each subsidiary maintains its own client relationships and brand identity while benefiting from group synergies, shared commercial resources, and coordinated business development by senior leaders including the CEO and Head of Medico-Marketing and Business Development. Pricing is custom and project-based, with multi-year contract cadences typical of enterprise healthcare engagements; no public pricing tiers or per-unit economics are disclosed. The group targets enterprise pharmaceutical, biotech, and medtech clients, and revenue is generated through project-based engagements and retainer contracts. The underlying technology stack is intentionally lean — value derives primarily from human expertise, with no proprietary platform or technology product at the core. The May 2025 partnership with UK-based Page & Page Health provides access to PIRL, an AI-powered insights tool that supports strategic decision-making and communication across engagements.

Following the October 2024 acquisitions, consolidated revenue reached approximately €15 million with a team of approximately 70 employees; the April 2025 integration of Rweality expanded headcount further. The group's stated strategic ambition is to reach several hundred million euros in revenue within five years through continued external growth. Enosium does not use resellers or intermediaries and operates through direct enterprise sales across the European market.

Enosium Life Science firmographics

Firmographics
Name
Enosium Life Science
Legal name
Advisantis Consulting SARL
Website
https://enosium.com
Company type
Private
Founded year
2024
Operating status
Operating
Headcount range
1–10 employees
Short description
Enosium Life Science is a Paris-based European scientific services group that provides consulting in clinical research, regulatory affairs, market access, medical affairs, and marketing to pharmaceutical, biotech, and medtech companies, built through a Buy & Build acquisition strategy.
Ownership category
akta.pro rank

Enosium Life Science industry classification

Industry
Product category
Pharmaceutical Consulting Services
NAICS
Other Scientific and Technical Consulting Services (54169), Other Scientific and Technical Consulting Services (541690), Professional, Scientific, and Technical Services (541)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Engineering, Accounting, Research, Management (8700), Services-Misc Health & Allied Services, Nec (8090)
akta.pro industry
PRIMARYHLAGAKAI
Clinical Quality Assurance (GCP QA, TMF/QMS oversight)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAKAL
Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAKAO
Third-Party/Outsourced Quality & Responsible Person Services (EU QP/RP, US Agent)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYMPAAADAD
Healthcare & Life Sciences PR
Media, Entertainment & Sports/Advertising, Marketing & PR Services/Public Relations & Communications Agencies

Keywords

  • Clinical research services
  • Market access consulting
  • Health economics research
  • Regulatory affairs consulting
  • Medical affairs services

Where Enosium Life Science is headquartered

Location

Headquarters

HQ city
Paris
HQ country
France
HQ region
Europe

Offices1 record

Markets served

Enosium Life Science business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Scientific Consulting Services: Enosium Life Science generates revenue through providing specialized scientific consulting services to pharmaceutical, biotech and medtech companies across five core areas: clinical research (CRO), regulatory affairs, market access and health economics, medical affairs, and marketing. Services include strategic advisory, clinical studies, medical writing, biostatistics, market access strategy, pricing strategy, scientific communication, and marketing campaign development. Revenue is generated through project-based engagements and retainer contracts with healthcare industry clients.
  2. Subsidiary Service Revenue: Each subsidiary (Inbeeo, Vyoo Agency, KPL Paris, Sirius Customizer, Alinéa Plus, Rweality) provides specialized services that contribute to the group's consolidated revenue. Each operates with its own client relationships while benefiting from group synergies and commercial resources.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom project-based engagements for pharmaceutical and biotech clients

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Enosium Life Science product offering

Product offering

Core offering

Enosium Life Science is a European scientific services group that delivers specialized consulting across the healthcare product value chain for pharmaceutical, biotech, and medtech companies. Its offering spans five integrated pillars — clinical research (CRO), regulatory affairs, market access & health economics, medical affairs, and marketing — delivered through six wholly-owned subsidiaries (Inbeeo, Vyoo Agency, KPL Paris, Sirius Customizer, Alinéa Plus, Rweality) operating across France, the UK, and broader Europe.

Product overview

Enosium Life Science is a European integrated scientific services group offering a portfolio of complementary subsidiaries and five core service pillars covering the entire healthcare product value chain. The group comprises six acquired specialized companies: Inbeeo (market access/pricing strategy), Vyoo Agency (health economics/HEOR), KPL Paris (medical affairs), Sirius Customizer (strategic consulting/patient journey), Alinéa Plus (scientific events/publishing), and Rweality (real-world evidence/HTA). These subsidiaries operate alongside five integrated service pillars: Clinical Research (CRO), Regulatory Affairs, Market Access & Health Economics, Medical Affairs, and Marketing & Commercial Strategies. The model combines local expertise with international reach, serving pharmaceutical, biotech, and MedTech industries across Europe.

Differentiator

Problem solved

Functional benefit

Products and services

  • Inbeeo Market access and pricing strategy consulting for pharmaceutical and MedTech companies in Europe, using a data-driven approach to define, communicate, and optimize innovation value from clinical development through lifecycle management.
  • Vyoo Agency Health economics and outcomes research (HEOR) consultancy providing cost-effectiveness and budget impact analyses using advanced modeling tools to compare and prioritize medical strategies based on clinical benefit and economic efficiency.
  • KPL Paris Medical affairs consultancy in France dedicated to developing and executing tailored medical and medico-marketing strategies, including data analysis, medical education, KOL management, digital transformation, and patient experience optimization.
  • Sirius Customizer Strategic consulting firm for the health, pharma, and MedTech sectors, providing care pathway optimization, market access strategies, public affairs, and communication through a network of experts.
  • Alinéa Plus Scientific events and medical publishing specialist with over 20 years of experience, offering tailored solutions for in-person, digital, and hybrid events and collaborating with scientific societies.
  • Rweality Real-world evidence (RWE) and health technology assessment consultancy providing end-to-end solutions including RWE generation, market access and pricing strategy, HEOR, organizational impact on healthcare systems, and field market access operations.
  • Clinical Research (CRO) Clinical research services spanning Phase III through real-world studies and early access programs, including clinical studies, medical writing, biostatistics, real-world data, and early access expertise for pharmaceutical and biotech clients.
  • Regulatory Affairs Regulatory strategy, submission, pharmacovigilance, quality assurance, and regulatory compliance services for healthcare products across European markets.
  • Market Access & Health Economics Access strategy, HEOR, pricing and reimbursement, value-based healthcare, and public affairs services designed to optimize market access and demonstrate product value to payers and health systems.
  • Medical Affairs Medical strategy, scientific communication, data generation, and medical education/training services to support medical stakeholders and drive evidence-based healthcare decisions.
  • Marketing & Commercial Strategies Brand strategy, communication campaigns, multi-channel marketing, market research, and go-to-market and commercial excellence services for pharmaceutical and healthcare products.

Companies that use Enosium Life Science

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Enosium Life Science technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature1 record

Enosium Life Science partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered flagship and core.

  • Page & Page HealthflagshipStrategic or Co-development Partner · 12 May 2025Strategic partnership announced May 12, 2025 between Enosium Life Science and UK-based Page & Page Health. The alliance combines scientific, strategic, creative, and commercial expertise to provide end-to-end solutions for pharmaceutical, biotech, and medtech companies throughout the product lifecycle. Key element is access to PIRL, Page & Page Health's AI-powered insights tool. The partnership enables earlier value articulation in product lifecycles and provides clients with integrated support from clinical development through commercialization.
  • RwealitycoreOthers · 1 April 2025Rweality was acquired by Enosium Life Science in April 2025. It is a consulting firm specializing in real-world evidence and health technology assessment. Rweality brings expertise in market access, pricing strategy, health economics (HEOR), organizational impact on healthcare systems, and field market access operations. The acquisition strengthens Enosium's capabilities in healthcare data valuation and market access services.
  • InbeeocoreOthers · 3 October 2024Inbeeo is a leading consulting firm specializing in market access and pricing strategies for pharmaceutical drugs and medical devices in Europe. Specializes in data-driven approaches to help define, communicate, and optimize the value of innovations from clinical development to lifecycle management.
  • Vyoo AgencycoreOthers · 3 October 2024Vyoo Agency is one of the few companies highly specialized in health economics and outcomes research (HEOR). Provides cost-effectiveness and budget impact analyses using advanced modeling tools to compare and prioritize medical strategies based on clinical benefit and economic efficiency.
  • Epione Group (KPL, Alinéa Plus, Sirius Customizer)coreOthers · 3 October 2024Epione Group comprises three entities: KPL (French specialist in medical affairs and medico-marketing strategies), Alinéa Plus (expert in scientific events and medical publishing with over 20 years of experience), and Sirius Customizer (strategic consulting for care pathway optimization and market access). The group brings expertise in medical communication, scientific events, and patient journey optimization.

Scale indicators5 records

Recent moves4 records

Expansion highlights5 records

Enosium Life Science competitors and assessment

Company assessment

Broad incumbents

  • SGS SA: Swiss-based testing, inspection, and certification giant with a life sciences division offering CRO and consulting services. Similar Buy & Build DNA applied across life sciences services, with greater scale and global footprint.
  • IQVIA: Global leader in clinical research, real-world evidence, and life sciences consulting. IQVIA competes with Enosium's CRO and market access pillars at the enterprise scale Enosium aspires to reach, and serves the same pharma/biotech client base.
  • Syneos Health: Biopharma solutions organization combining CRO services with commercial and medical affairs capabilities. Closely mirrors Enosium's combined CRO + Medical Affairs + Marketing pillars, serving the same pharmaceutical clients.
  • Parexel International: Global CRO and biopharmaceutical services provider offering clinical research, regulatory, and market access services. Competes with Enosium across multiple pillars and serves the same European pharma client base.
  • Eurofins Scientific: European-headquartered life sciences services conglomerate built through aggressive M&A. Comparable to Enosium's PE-backed Buy & Build strategy applied to life sciences services, though at much larger scale.
  • ICON plc: Major global CRO offering clinical research, laboratory, and consulting services. Directly comparable to Enosium's Clinical Research pillar and competes for the same enterprise pharma clients across Europe.
  • Charles River Laboratories: Major life sciences services platform offering CRO, research models, and consulting services. A benchmark for what a mature, scaled life sciences services roll-up can become — relevant peer for Enosium's growth trajectory.

Direct peers

  • ZS Associates: Global consulting firm specializing in pharmaceutical sales, marketing, and market access strategy. Directly competes with Enosium's Market Access and Commercial Strategies pillars for pharma client engagements.
  • Pharmalex (PharmaLex): European-headquartered regulatory affairs and pharmacovigilance consulting firm, also built through PE-backed roll-up strategy. Most directly comparable peer to Enosium, competing in regulatory affairs, market access, and quality compliance.

Others

  • Page & Page Health: UK-based healthcare communications agency and Enosium's strategic partner. Provides communications, creative, and PIRL AI insights capabilities to Enosium clients; adjacent service provider rather than competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Enosium Life Science social profiles

Digital presence

Enosium Life Science financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Enosium Life Science leadership team

Management profile

Number of profiles

Profiles5 records

Enosium Life Science subsidiaries and ownership

Company hierarchy

Subsidiaries7 records

Enosium Life Science funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Enosium Life Science M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Enosium Life Science

What does Enosium Life Science do?

Enosium Life Science is a European scientific services group that delivers specialized consulting across the healthcare product value chain for pharmaceutical, biotech, and medtech companies. Its offering spans five integrated pillars — clinical research (CRO), regulatory affairs, market access & health economics, medical affairs, and marketing — delivered through six wholly-owned subsidiaries (Inbeeo, Vyoo Agency, KPL Paris, Sirius Customizer, Alinéa Plus, Rweality) operating across France, the UK, and broader Europe.

Is Enosium Life Science a public or private company?

Enosium Life Science is a private company. It is classified as private equity controlled and is currently operating.

When was Enosium Life Science founded?

Enosium Life Science was founded in 2024. It employs 1 to 10 people.

Where is Enosium Life Science based?

Enosium Life Science is headquartered in Paris, France, in the Europe region.

How does Enosium Life Science make money?

Two revenue lines are on record. Scientific Consulting Services are the primary driver. The others are subsidiary Service Revenue.

Who are Enosium Life Science's main competitors?

Broad incumbents on record are SGS SA, IQVIA, Syneos Health, Parexel International, Eurofins Scientific, ICON plc and Charles River Laboratories. Direct peers are ZS Associates and Pharmalex (PharmaLex). Page & Page Health is listed as an others.

Does Enosium Life Science have an API?

No public API is recorded for Enosium Life Science.

What industry is Enosium Life Science in?

Enosium Life Science's product category is Pharmaceutical Consulting Services. Its primary akta.pro industry code is HLAGAKAI, Clinical Quality Assurance (GCP QA, TMF/QMS oversight), with a secondary code of HLAGAKAL, Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control). Its NAICS code is 54169 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals